APA (7th ed.) Citation

Koschitzky, M., Navrazhina, K., Garshick, M. S., Gonzalez, J., Han, J., Garcet, S., & Krueger, J. G. (2022). Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris. Experimental Dermatology, 31(9), 1341. https://doi.org/10.1111/exd.14582

Chicago Style (17th ed.) Citation

Koschitzky, Merav, Kristina Navrazhina, Michael S. Garshick, Juana Gonzalez, Joseph Han, Sandra Garcet, and James G. Krueger. "Ustekinumab Reduces Serum Protein Levels Associated with Cardiovascular Risk in Psoriasis Vulgaris." Experimental Dermatology 31, no. 9 (2022): 1341. https://doi.org/10.1111/exd.14582.

MLA (9th ed.) Citation

Koschitzky, Merav, et al. "Ustekinumab Reduces Serum Protein Levels Associated with Cardiovascular Risk in Psoriasis Vulgaris." Experimental Dermatology, vol. 31, no. 9, 2022, p. 1341, https://doi.org/10.1111/exd.14582.